Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
2.540
+0.265 (11.65%)
Sep 2, 2025, 10:48 AM - Market open

Entero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
43351829
Upgrade
Market Cap Growth
-37.39%4.30%-44.22%-71.75%-38.93%6.53%
Upgrade
Enterprise Value
464-041118
Upgrade
Last Close Price
2.271.8712.60367.7518207.02122220.12
Upgrade
PB Ratio
0.070.050.791.85-2.30-11.15
Upgrade
P/TBV Ratio
--1.484.80--
Upgrade
Debt / Equity Ratio
0.020.000.230.32-0.13-0.24
Upgrade
Quick Ratio
00.011.190.590.670.43
Upgrade
Current Ratio
2.813.031.581.370.770.51
Upgrade
Return on Equity (ROE)
-24.28%-50.87%-497.87%---3305.91%
Upgrade
Return on Assets (ROA)
-3.32%-21.16%-159.97%-91.98%-286.81%-151.38%
Upgrade
Return on Capital (ROIC)
-4.47%-31.30%-244.72%---784.82%
Upgrade
Earnings Yield
-475.61%-610.73%-557.14%-287.85%-325.42%-110.92%
Upgrade
FCF Yield
-79.19%-311.73%-436.61%-439.64%-179.88%-38.11%
Upgrade
Buyback Yield / Dilution
-274.61%-921.26%-836.55%---
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q